Previous 10 | Next 10 |
2024-02-06 13:37:49 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...
Tenax Therapeutics, Inc. (NASDAQ: TENX) is one of today's top gainers. The company's shares have moved 82.38% on the day to $15.94. Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary di...
2024-02-06 10:01:21 ET Tenax Therapeutic Inc (NASDAQ: TENX) opened nearly 150% up this morning after receiving approval for a patent application. Tenax Therapeutics stock rallies ahead of earnings The U.S. Patent and Trademark Office accepted its patent application for levosimen...
2024-02-06 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...
Once granted, this patent will: provide U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond 2040 broaden IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active ...
2024-01-25 12:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-03 12:43:51 ET More on Mid-day movers & stocks. Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Financial information for Airship AI Holdings, Inc. Financial information...
2024-01-02 08:02:09 ET Tenax Therapeutics Inc (TENX) announced stock split at a ratio of 1-for-80 on 2024-01-03 ... Full story available on KlickAnalytics.com
2023-12-29 08:35:01 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...
2023-12-04 06:55:43 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...
News, Short Squeeze, Breakout and More Instantly...
Tenax Therapeutics Inc. Company Name:
TENX Stock Symbol:
NASDAQ Market:
Tenax Therapeutics Inc. Website:
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF Provides U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond ...